Chengdu Zihao Pharmaceutical

Chengdu Zihao Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, focused on the research, development, and large-scale production of chemical drugs and traditional Chinese medicine (TCM). The company operates modern, GMP-certified manufacturing facilities that produce a variety of dosage forms, including large and small volume injections, tablets, and capsules. Its primary therapeutic focus areas include cardiovascular and cerebrovascular diseases, respiratory ailments, and anti-infective treatments. Key products in its portfolio include Panax Notoginseng Saponins (Xuesaitong) and Ambroxol Hydrochloride, which are widely distributed across the Chinese healthcare market. Zihao Pharmaceutical emphasizes quality control and technological innovation to maintain its position in the domestic pharmaceutical industry.